Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NM › Albuquerque › NPI 1306914213
Physician

Lovelace Health System LLC

Lovelace Health System LLC was paid $45.27M by Medicaid between Jan 2018 and Dec 2024, across 289 billing codes. Its largest line is 99284, emergency room visit (serious) — 15% of everything it billed.

33Billing provider infoLOVELACE HEALTH SYSTEM LLC
ALBUQUERQUE, NM 87102
33aNPI1306914213assigned 11/30/2006
33bProvider typeInterventional Cardiology Physician
28Total paid$45.27M
24GClaims788,116
24DCodes billed289
24AFirst – last monthJan 2018 – Dec 2024

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official PETROVICH, STEPHEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018129,982$7.35M
2019101,948$6.19M
202086,487$5.36M
2021100,536$5.79M
2022121,623$6.36M
2023132,836$7.49M
2024incomplete114,704$6.74M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 33,081 30,657 $6.63M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 14% 25,725 24,089 $6.43M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 9.3% 28,696 26,163 $4.19M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.8% 6,735 6,474 $2.16M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.2% 23,278 22,064 $1.92M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 3.8% 5,711 5,595 $1.74M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3.5% 36,487 31,077 $1.57M
70450 Computed tomography, head or brain; without contrast material 2.4% 6,456 6,179 $1.07M
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 2.2% 2,021 1,938 $993K
80053 Comprehensive metabolic panel 2.2% 45,461 38,369 $974K
G0378 Hospital observation service, per hour 2.1% 2,646 2,421 $969K
93458 1.9% 490 483 $840K
277 more codes
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.3% 5,821 $597K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 18,756 $597K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 52,313 $561K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 2,342 $552K
93017 1.1% 3,163 $496K
96375 Therapeutic injection; each additional sequential IV push 1.1% 11,746 $493K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.1% 6,900 $484K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.1% 7,811 $475K
96361 Intravenous infusion, hydration; each additional hour 1.0% 6,462 $471K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,695 $427K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 926 $405K
49083 <1% 1,126 $361K
71045 Radiologic examination, chest; single view <1% 11,058 $356K
71046 Radiologic examination, chest; 2 views <1% 7,707 $344K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 1,120 $333K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,119 $295K
C1776 Joint device (implantable) <1% 195 $289K
84484 <1% 17,722 $260K
72125 Computed tomography, cervical spine; without contrast material <1% 1,340 $247K
70551 Magnetic resonance imaging, brain; without contrast material <1% 834 $224K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,355 $221K
36415 Collection of venous blood by venipuncture <1% 56,629 $217K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,408 $208K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,212 $193K
83690 <1% 12,688 $183K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,990 $172K
84703 <1% 10,116 $167K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 14,098 $164K
99152 <1% 3,027 $161K
93976 <1% 1,343 $149K
87040 <1% 5,464 $149K
71250 <1% 1,050 $146K
87086 Culture, bacterial; quantitative colony count, urine <1% 9,078 $135K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,812 $133K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,400 $125K
82962 <1% 16,570 $124K
70486 <1% 651 $123K
80048 Basic metabolic panel (calcium, ionized) <1% 8,984 $120K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 635 $120K
81001 <1% 18,083 $117K
99153 Mod sedat endo service >5yrs <1% 1,954 $114K
C1769 Guide wire <1% 3,766 $114K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 872 $105K
73562 <1% 1,575 $105K
83605 <1% 5,191 $105K
J2785 Injection, regadenoson, 0.1 mg <1% 1,595 $104K
93970 <1% 905 $104K
93971 <1% 1,339 $103K
73030 <1% 1,518 $101K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 279 $101K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 1,006 $97K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 341 $94K
83735 <1% 9,948 $90K
83880 <1% 3,719 $87K
C9290 Injection, bupivacaine liposome, 1 mg <1% 331 $87K
96376 <1% 3,296 $86K
87631 <1% 1,048 $85K
93296 <1% 4,024 $81K
93350 <1% 224 $76K
85610 <1% 11,953 $74K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 1,959 $73K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 658 $65K
73610 <1% 916 $65K
73130 <1% 1,195 $64K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 209 $61K
84443 Thyroid stimulating hormone (TSH) <1% 2,947 $54K
73630 <1% 952 $54K
97163 <1% 1,104 $53K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 1,265 $51K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,578 $49K
97167 <1% 911 $47K
93925 <1% 558 $47K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 2,953 $45K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,944 $45K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 2,006 $43K
93246 <1% 814 $40K
94761 <1% 3,197 $39K
86850 <1% 3,852 $39K
72131 <1% 231 $39K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 637 $37K
85379 <1% 2,410 $35K
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,282 $35K
76536 <1% 353 $34K
99490 Ccm add 20min <1% 1,036 $34K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 286 $33K
72100 <1% 429 $32K
87186 <1% 2,091 $31K
87077 <1% 2,885 $31K
93880 <1% 293 $31K
76830 Ultrasound, transvaginal <1% 323 $30K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 660 $30K
93922 <1% 444 $29K
73502 <1% 662 $29K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,417 $28K
67113 <1% 12 $28K
85730 <1% 3,655 $28K
J2704 Injection, propofol, 10 mg <1% 4,362 $26K
64635 <1% 57 $26K
93325 <1% 423 $25K
86900 <1% 4,038 $25K
81003 <1% 6,742 $24K
C1732 Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping <1% 53 $23K
87081 <1% 1,651 $23K
84702 <1% 946 $22K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 232 $22K
73110 <1% 404 $21K
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 287 $20K
93320 <1% 285 $19K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 515 $18K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 517 $18K
82803 <1% 947 $18K
J1644 Injection, heparin sodium, per 1000 units <1% 3,475 $17K
83036 Hemoglobin; glycosylated (A1C) <1% 2,125 $17K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 1,974 $16K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 12 $16K
86901 <1% 4,039 $16K
75625 <1% 13 $16K
90715 <1% 1,265 $15K
75574 <1% 62 $14K
74018 <1% 363 $14K
72114 <1% 151 $14K
76942 <1% 241 $14K
C1729 Catheter, drainage <1% 2,400 $14K
80143 <1% 1,510 $13K
80179 <1% 1,482 $13K
12001 <1% 140 $13K
80061 Lipid panel <1% 1,015 $13K
84439 <1% 846 $12K
10060 <1% 125 $12K
64636 <1% 30 $12K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,210 $11K
85027 <1% 2,341 $10K
76770 <1% 123 $10K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 509 $10K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 144 $10K
87070 <1% 991 $10K
74183 <1% 25 $10K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,235 $9K
64447 <1% 12 $8K
99406 <1% 516 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 466 $8K
43235 <1% 26 $8K
87075 <1% 684 $8K
87650 <1% 291 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,604 $7K
72040 <1% 87 $7K
82150 <1% 540 $7K
76937 <1% 125 $7K
73700 <1% 41 $7K
73560 <1% 129 $6K
J7050 Infusion, normal saline solution, 250 cc <1% 1,231 $6K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 571 $6K
P9047 Infusion, albumin (human), 25%, 50 ml <1% 48 $6K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,149 $5K
73080 <1% 104 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,660 $5K
87632 <1% 37 $5K
86140 <1% 787 $5K
77334 <1% 19 $5K
J0690 Injection, cefazolin sodium, 500 mg <1% 3,587 $5K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 39 $5K
93242 <1% 155 $5K
93280 <1% 262 $5K
94760 <1% 275 $5K
87205 <1% 961 $5K
99439 <1% 271 $4K
82140 <1% 211 $4K
97162 <1% 118 $4K
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries <1% 12 $4K
72141 <1% 13 $4K
J3473 Injection, hyaluronidase, recombinant, 1 usp unit <1% 533 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,473 $4K
71101 <1% 53 $4K
70496 <1% 12 $4K
84481 <1% 198 $3K
93297 <1% 474 $3K
97116 <1% 206 $3K
C1726 Catheter, balloon dilatation, non-vascular <1% 28 $3K
C1760 Closure device, vascular (implantable/insertable) <1% 49 $3K
82330 <1% 270 $3K
C9113 Injection, pantoprazole sodium, per vial <1% 1,243 $3K
85347 <1% 528 $3K
97535 Self-care/home management training, each 15 minutes <1% 112 $3K
85014 <1% 797 $3K
82550 <1% 311 $3K
C1759 Catheter, intracardiac echocardiography <1% 25 $3K
84132 <1% 534 $3K
A9270 Non-covered item or service <1% 5,916 $3K
82553 <1% 201 $2K
87634 <1% 69 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,678 $2K
84100 <1% 490 $2K
72110 <1% 25 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,359 $2K
85652 <1% 374 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 47 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 886 $2K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 31 $2K
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 80 $1K
73590 <1% 28 $1K
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml <1% 47 $1K
72170 <1% 25 $1K
85018 <1% 432 $1K
86923 <1% 32 $1K
72070 <1% 13 $1K
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 421 $1K
J2060 Injection, lorazepam, 2 mg <1% 877 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 282 $1K
76870 <1% 13 $1K
71271 <1% 13 $1K
J1815 Injection, insulin, per 5 units <1% 906 $1K
85007 <1% 292 $1K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 438 $1K
81025 <1% 146 $1K
76801 <1% 13 $1K
93284 <1% 65 $1K
0296T <1% 13 $981.21
12002 <1% 12 $980.02
J0780 Injection, prochlorperazine, up to 10 mg <1% 403 $953.83
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 88 $910.84
93298 <1% 176 $898.78
72050 <1% 13 $891.73
84295 <1% 121 $888.52
J3475 Injection, magnesium sulfate, per 500 mg <1% 153 $790.93
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 726 $778.51
J3370 Injection, vancomycin hcl, 500 mg <1% 122 $748.10
80050 General health panel <1% 24 $683.03
93978 <1% 12 $670.11
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 480 $669.69
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 383 $654.99
C1766 Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away <1% 12 $484.98
97802 <1% 28 $467.83
J3371 Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg <1% 186 $466.31
A4615 Cannula, nasal <1% 1,917 $464.96
80076 <1% 31 $459.89
J3480 Injection, potassium chloride, per 2 meq <1% 70 $424.00
82565 <1% 99 $412.37
J2305 Injection, nitroglycerin, 5 mg <1% 165 $361.37
84134 <1% 27 $352.80
J0687 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg <1% 236 $343.41
J1790 Injection, droperidol, up to 5 mg <1% 281 $343.07
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 124 $321.05
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 572 $313.25
87641 <1% 17 $312.73
J1940 Injection, furosemide, up to 20 mg <1% 312 $311.04
J1650 Injection, enoxaparin sodium, 10 mg <1% 233 $299.95
J3490 Unclassified drugs <1% 13 $229.23
J1596 Injection, glycopyrrolate, 0.1 mg <1% 132 $177.18
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 55 $146.11
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 29 $134.05
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 230 $131.52
99487 Ccm add 20min <1% 15 $114.76
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 29 $113.76
89051 <1% 20 $94.49
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 150 $93.80
84145 <1% 15 $90.11
J3360 Injection, diazepam, up to 5 mg <1% 36 $87.21
J2470 Injection, pantoprazole sodium, 40 mg <1% 114 $86.46
J1171 Injection, hydromorphone, 0.1 mg <1% 30 $68.16
J2800 Injection, methocarbamol, up to 10 ml <1% 12 $64.48
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 26 $60.82
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 80 $49.70
J1630 Injection, haloperidol, up to 5 mg <1% 27 $30.69
J0360 Injection, hydralazine hcl, up to 20 mg <1% 14 $20.53
J2720 Injection, protamine sulfate, per 10 mg <1% 25 $20.31
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 13 $19.64
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 13 $17.44
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 1,067 $0.01
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 204 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 203 $0.00
G8989 Self care functional limitation, discharge status, at discharge from therapy or to end reporting 0% 84 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 137 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 203 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 136 $0.00
V2632 Posterior chamber intraocular lens 0% 15 $0.00
77001 0% 13 $0.00
99489 Ccm add 20min 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPETROVICH, STEPHEN (CFO)
Parent organizationARDENT LEGACY HOLDINGS, LLC
Same official

Other billing entities under PETROVICH, STEPHEN

Full network →
ProviderLocationPaid
Lovelace Health System, LLCAlbuquerque, NM$57.71M
Southwest Medical Associates, LLCAlbuquerque, NM$41.40M
Lovelace Health System, LLCAlbuquerque, NM$31.24M
Lovelace Health System LLCRoswell, NM$20.13M
Jacksonville Hospital LLCJacksonville, TX$9.41M
Henderson Hospital, LLCHenderson, TX$8.52M
Athens Hospital, LLCAthens, TX$8.32M
Etmc Physician Group INC.Tyler, TX$8.03M
Tyler Regional Hospital LLCTyler, TX$7.94M
Lovelace Unm Rehabilitation Hospital LLCAlbuquerque, NM$6.30M
Pocatello Hospital LLCPocatello, ID$6.11M
Jacksonville Hospital LLCJacksonville, TX$5.93M
Ahs Pryor Hospital, LLCPryor, OK$5.61M
Bsa Hospital LLCAmarillo, TX$4.96M
Pittsburg Hospital LLCPittsburg, TX$4.83M
Ahs Claremore Regional Hospital, LLC.Claremore, OK$4.81M
Ahs Henryetta Hospital LLCHenryetta, OK$4.27M
Pittsburg Hospital LLCPittsburg, TX$3.98M
Topeka Hospital, LLCTopeka, KS$3.94M
Ahs Pryor Hospital, LLCPryor, OK$3.76M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.